ADGRE5-centered Tsurv model in T cells recognizes responders to neoadjuvant cancer immunotherapy

ADGRE5-centered Tsurv model in T cells recognizes responders to neoadjuvant cancer immunotherapy

BackgroundNeoadjuvant immunotherapy with anti-programmed death-1 (neo-antiPD1) has revolutionized perioperative methods for improvement of overall survival (OS), while approaches for major pathologic response patients’ (MPR) recognition along with methods for overcoming non-MPR resistance are still...

Full description

Bibliographic Details
Main Authors: Jian Li, Zhouwenli Meng, Zhengqi Cao, Wenqing Lu, Yi Yang, Ziming Li, Shun Lu
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Immunology
Subjects:
non-small cell lung cancer
neo-adjuvant immunotherapy therapy
tumor microenvironment
ScRNA-seq
multimodal
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1304183/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2024.1304183/full

Similar Items